Shelter Pharma is launching a new healthcare/nutraceutical product, namely ‘FOLIMAN Folic Acid Tablets’ (Vitamin B-9 Supplement), on May 11, 2026, as part of its business expansion and product portfolio enhancement strategy. The launch is expected to strengthen the company’s presence in the healthcare segment and contribute towards future business growth. The product is being launched in the international market, and the company may subsequently introduce the same in the domestic market in due course.
Shelter Pharma is engaged in the business of manufacturing herbal products with well-built presence in Human Pharma as well as Veterinary.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1806.45 |
| Dr. Reddys Lab | 1279.25 |
| Cipla | 1381.50 |
| Zydus Lifesciences | 1087.75 |
| Lupin | 2273.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: